T1	intervention 77 113	pectoral nerves (Pecs) block type II
T2	total-participants 403 406	140
T3	eligibility 407 523	breast cancer stage 1-3 patients undergoing mastectomy or tumorectomy with sentinel node or axillary node dissection
T4	control 618 625	placebo
T5	intervention-participants 611 613	70
T6	control-participants 647 649	70
T10	outcome 1057 1095	Intraoperative sufentanil requirements
T11	outcome 1237 1241	pain
T12	outcome 1377 1398	postoperative opioids
T13	outcome 1492 1526	postsurgical opioid administration
T14	outcome 1617 1626	satisfied
T15	iv-cont-mean 1144 1147	8.0
T21	iv-cont-sd 1148 1153	3.5μg
T16	cv-cont-mean 1158 1161	7.8
T22	cv-cont-sd 1162 1167	3.0μg
T17	iv-cont-mean 1400 1404	9.16
T23	iv-cont-sd 1405 1412	10.15mg
T18	cv-cont-mean 1417 1422	14.97
T24	cv-cont-sd 1423 1430	14.38mg
T19	iv-cont-mean 1651 1654	9.6
T25	iv-cont-sd 1655 1658	0.6
T20	cv-cont-mean 1663 1666	9.1
T26	cv-cont-sd 1667 1670	1.8
